| Primary |
| Gastrooesophageal Reflux Disease |
47.0% |
| Hypertension |
10.0% |
| Dyspepsia |
5.2% |
| Diabetes Mellitus |
4.0% |
| Depression |
3.4% |
| Blood Cholesterol Increased |
2.9% |
| Intervertebral Disc Protrusion |
2.7% |
| Hiatus Hernia |
2.4% |
| Gastric Disorder |
2.3% |
| Abdominal Discomfort |
2.3% |
| Nausea |
2.2% |
| Pain |
2.2% |
| Ulcer |
2.1% |
| Gastritis |
1.9% |
| Asthma |
1.8% |
| Barrett's Oesophagus |
1.8% |
| Anxiety |
1.5% |
| Hyperchlorhydria |
1.5% |
| Vomiting |
1.4% |
| Thyroid Disorder |
1.3% |
|
| Drug Ineffective |
12.9% |
| Drug Screen Positive |
12.7% |
| Drug Screen False Positive |
10.5% |
| Malaise |
7.8% |
| Death |
7.1% |
| Vomiting |
5.4% |
| Nausea |
4.4% |
| Gastrooesophageal Reflux Disease |
3.9% |
| Weight Decreased |
3.9% |
| Pain |
3.7% |
| Drug Hypersensitivity |
3.2% |
| No Adverse Event |
3.2% |
| Cerebrovascular Accident |
3.1% |
| Dyspepsia |
2.8% |
| Chest Pain |
2.7% |
| Rash |
2.7% |
| Hypertension |
2.6% |
| Pruritus |
2.6% |
| Drug Effect Decreased |
2.5% |
| Abdominal Pain Upper |
2.3% |
|
| Secondary |
| Gastrooesophageal Reflux Disease |
21.0% |
| Product Used For Unknown Indication |
12.7% |
| Depression |
7.9% |
| Anxiety |
6.7% |
| Hypertension |
6.5% |
| Blood Cholesterol Increased |
5.1% |
| Lower Limb Fracture |
4.3% |
| Spinal Fracture |
4.3% |
| Diabetes Mellitus |
3.7% |
| Type 2 Diabetes Mellitus |
3.6% |
| Gastric Disorder |
3.5% |
| Nerve Injury |
2.9% |
| Dyspepsia |
2.7% |
| Pain |
2.4% |
| Drug Use For Unknown Indication |
2.4% |
| Head Discomfort |
2.1% |
| Head Injury |
2.1% |
| Gastritis |
2.1% |
| Fibromyalgia |
2.0% |
| Cardiac Disorder |
1.9% |
|
| Drug Ineffective |
11.0% |
| Death |
9.7% |
| Malaise |
9.3% |
| Weight Decreased |
9.0% |
| Pain |
8.1% |
| Vomiting |
7.0% |
| Gastrooesophageal Reflux Disease |
5.3% |
| Cerebrovascular Accident |
4.6% |
| Thrombosis |
4.0% |
| Cardiac Disorder |
3.7% |
| Hypertension |
3.3% |
| Asthma |
3.1% |
| Nausea |
3.1% |
| Urticaria |
3.1% |
| Convulsion |
2.9% |
| Chest Discomfort |
2.6% |
| Dyspepsia |
2.6% |
| Myocardial Infarction |
2.6% |
| Arthropathy |
2.4% |
| Dry Mouth |
2.4% |
|
| Concomitant |
| Product Used For Unknown Indication |
28.3% |
| Drug Use For Unknown Indication |
18.3% |
| Gastrooesophageal Reflux Disease |
6.5% |
| Pain |
6.2% |
| Hypertension |
6.1% |
| Depression |
4.2% |
| Multiple Myeloma |
3.6% |
| Anxiety |
3.0% |
| Diabetes Mellitus |
2.7% |
| Rheumatoid Arthritis |
2.5% |
| Crohn's Disease |
2.5% |
| Asthma |
2.4% |
| Nausea |
2.2% |
| Osteoporosis |
2.1% |
| Blood Cholesterol Increased |
1.7% |
| Prophylaxis |
1.7% |
| Insomnia |
1.7% |
| Atrial Fibrillation |
1.5% |
| Chronic Obstructive Pulmonary Disease |
1.5% |
| Multiple Sclerosis |
1.4% |
|
| Vomiting |
15.6% |
| Weight Decreased |
12.4% |
| Weight Increased |
7.5% |
| Nausea |
5.6% |
| Urinary Tract Infection |
5.5% |
| Pain |
5.0% |
| Pulmonary Embolism |
4.5% |
| Type 2 Diabetes Mellitus |
4.3% |
| Death |
4.1% |
| Myocardial Infarction |
4.0% |
| Pneumonia |
4.0% |
| Drug Ineffective |
3.4% |
| White Blood Cell Count Decreased |
3.4% |
| Tremor |
3.4% |
| Vision Blurred |
3.1% |
| Pyrexia |
3.0% |
| Thrombocytopenia |
3.0% |
| Rash |
2.8% |
| Renal Failure Acute |
2.7% |
| Dyspnoea |
2.7% |
|
| Interacting |
| Gastrooesophageal Reflux Disease |
15.9% |
| Drug Use For Unknown Indication |
13.2% |
| Hypertension |
13.2% |
| Dyspepsia |
7.7% |
| Gastric Disorder |
6.6% |
| Abdominal Pain Upper |
5.5% |
| Stent Placement |
4.4% |
| Diabetes Mellitus |
3.8% |
| Neuropathy Peripheral |
3.3% |
| Product Used For Unknown Indication |
3.3% |
| Prostatic Disorder |
3.3% |
| Thyroid Disorder |
2.7% |
| Back Pain |
2.2% |
| Blood Cholesterol Increased |
2.2% |
| Heart Rate Increased |
2.2% |
| Hiatus Hernia |
2.2% |
| Hypercholesterolaemia |
2.2% |
| Myalgia |
2.2% |
| Oesophagitis |
2.2% |
| Atrial Fibrillation |
1.6% |
|
| Drug Interaction |
33.3% |
| Arthralgia |
8.3% |
| Pain In Extremity |
8.3% |
| Weight Decreased |
6.3% |
| Constipation |
4.2% |
| Dizziness Postural |
4.2% |
| Hypersensitivity |
4.2% |
| Neuropathy Peripheral |
4.2% |
| Skeletal Injury |
4.2% |
| Cardiac Arrest |
2.1% |
| Convulsion |
2.1% |
| Gastric Disorder |
2.1% |
| Gastric Haemorrhage |
2.1% |
| Gastrooesophageal Reflux Disease |
2.1% |
| Haemorrhoidal Haemorrhage |
2.1% |
| Inhibitory Drug Interaction |
2.1% |
| International Normalised Ratio Fluctuation |
2.1% |
| International Normalised Ratio Increased |
2.1% |
| Ischaemic Stroke |
2.1% |
| Loss Of Consciousness |
2.1% |
|
